117241 ⎘
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amidines (3.5.3) Arginase (3.5.3.1)
METHODS FOR TREATING NETOSIS AND NEUTROPHIL ACTIVATION
#2IMMUNOGENIC ARGINASE 2 POLYPEPTIDES
#3ARGINASE-INSULIN FUSION PROTEIN
#4METHODS FOR PRODUCTION OF HUMAN RECOMBINANT ARGINASE 1 AND USES THEREOF
#5NUCLEOTIDE DELIVERY OF CANCER THERAPY
#6TREATMENT OF ARGINASE 1 DEFICIENCY
#7ARGINASE1 POLYPEPTIDES
#8ARGINASE 2 VACCINE
#9Lyophilized Pharmaceutical Compositions Comprising A Lipid Nanoparticle
#10ARGINASE BEARING VESICLE COMPOSITION AND METHOD OF USE
#11DEGRADATION OF TOXINS IN VIVO
#12COMPOSITIONS AND METHODS FOR AMINO ACID DEPLETION THERAPY
#13ARGINASE AND ARGININOSUCCINATE SYNTHASE FOR CANCER THERAPY
#14Lyophilized Pharmaceutical Compositions Comprising a Lipid Nanoparticle
#15Tropane Alkaloid Transporters and Methods of Making Tropane Alkaloids Using the Same
#16IMMUNOGENIC ARGINASE PEPTIDES
#17METHODS FOR PRODUCTION OF HUMAN RECOMBINANT ARGINASE 1 AND USES THEREOF
#18METHOD AND COMPOSITION FOR TREATING ARGINASE 1 DEFICIENCY
#19Compositions Of Engineered Human Arginases And Methods For Treating Cancer
#20ARGINASE 1 BINDERS FOR INHIBITING ARGINASE 1 ACTIVITY
#21PERSISTENT MEMORY T-CELL RESPONSES TO CANCER AND INFECTIOUS-DISEASE ANTIGENS BY MANIPULATION OF AMINO ACID-CATABOLISM PATHWAYS
#22METHODS OF TREATING VIRAL INFECTIONS USING ARGINASE
#23BINDING MOLECULES TO ARGINASE II [ARG2]
#24Cleavable lipids
#25TROPANE ALKALOID (TA) PRODUCING NON-PLANT HOST CELLS, AND METHODS OF MAKING AND USING THE SAME
#26ARTIFICIAL RECOMBINANT PROTEIN FOR IMPROVING PERFORMANCE OF ACTIVE PROTEIN OR POLYPEPTIDE AND USE THEREOF
#27CARRIER PROTEIN FOR IMPROVING PROPERTIES OF BIOACTIVE PROTEIN
#28ARGINASE1 polypeptides
#29Immunogenic arginase 2 polypeptides
#30Method of treating AML subtypes using arginine-depleting agents
#31Arginine depletion therapy for treatment of GAMT deficiency
#32COMPOSITIONS CONTAINING ARGINASE 1 FOR THE TREATMENT OF NEUROVASCULAR AND RETINAL VASCULAR DISORDERS
#33Methods For Production Of Human Recombinant Arginase 1 And Uses Thereof
#34Compositions and methods for amino acid depletion therapy
#35Immunogenic arginase peptides
#36Compositions Of Engineered Human Arginases And Methods For Treating Cancer
#37METHODS FOR TREATING NETOSIS AND NEUTROPHIL ACTIVATION
#38Compositions and Methods for Treating Cancer with Arginine Depletion and Immuno Oncology Agents
#39Cleavable lipids
#40Composition and Application of Arginine-depleting Agents for Cancer, Obesity, Metabolic Disorders, and Related Complications and Comorbidities
#41Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#42METHODS AND COMPOSITIONS FOR MODULATING THE IMMUNE SYSTEM WITH ARGINASE I
#43Immunogenic arginase peptides
#44Cleavable lipids
#45Method and composition for treating arginase 1 deficiency
#46Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#47Methods for treating netosis and neutrophil activation
#48COMPOSITIONS OF ENGINEERED HUMAN ARGINASES AND METHODS FOR TREATING CANCER
#49METHOD TO TREAT CANCER USING ARGININE DELPETOR AND ORNITHINE DECARBOXYLASE (ODC) INHIBITOR
#50Compositions and methods for treating cancer with arginine depletion and immuno oncology agents
#51Cleavable lipids
#52L-ornithine production in eukaryotic cells
#53Nanoplatforms for arginase, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase detection by posttranslational modification
#54Methods and compositions for modulating the immune system with arginase I
#55Cleavable Lipids
#56Compositions of engineered human arginases and methods for treating cancer
#57Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#58Methods and compositions for modulating the immune system with Arginase I
#59Methods and compositions for modulating the immune system with arginase I
#60Processes of producing a fermentation product
#61Human arginase and site-directed pegylated human arginase and the use thereof
#62Human arginase and pegylated human arginase and the use thereof
#63Cleavable lipids
#64Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#65Methods for treatment of inflammatory and infectious viral diseases
#66Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents
#67Methods for treatment of ocular diseases
#68Processes of producing a fermentation product
#69Compositions of engineered human arginases and methods for treating cancer
#70Methods for purifying pegylated arginase
#71ARGINASE II: A TARGET FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
#72Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents
#73Compositions of engineered human arginases and methods for treating cancer
#74EXPRESSION SYSTEM FOR RECOMBINANT HUMAN ARGINASE I
#75Arginase II: A Target treatment of aging heart and heart failure
#76Arginase II: a target for the prevention of atherosclerosis
#77COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ASTHMA OR OTHER ALLERGIC OR INFLAMMATORY DISEASES
#78Expression System for Recombinant Human Arginase I